Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Mosaic ImmunoEngineering Inc.

News headline image
Mosaic ImmunoEngineering Announces Completion of Exclusive Technology License Agreement with Case Western Reserve University
From Mosaic ImmunoEngineering Inc.
Via AccessWire
Topics Intellectual Property
Tickers CPMV
News headline image
Newly Published Data Further Support Mosaic ImmunoEngineering’s Lead Immuno-Oncology Candidate MIE-101 in Combination with OX40 Checkpoint Treatment in Melanoma
From Mosaic ImmunoEngineering Inc.
Via AccessWire
Tickers CPMV
News headline image
Mosaic ImmunoEngineering's Lead Immuno-Oncology Candidate MIE-101 Highlighted in Keynote Presentation
From Mosaic ImmunoEngineering Inc.
Via AccessWire
Tickers CPMV
News headline image
Mosaic ImmunoEngineering Announces Upcoming Presentation at the 23rd Annual SoCalBio Conference
From Mosaic ImmunoEngineering Inc.
Via AccessWire
Tickers CPMV
News headline image
Spotlight Presentation at the World Molecular Imaging Congress Highlights Mosaic ImmunoEngineering's Immuno-Oncology and Modular Vaccine Platform Candidates
From Mosaic ImmunoEngineering Inc.
Via AccessWire
Tickers CPMV
News headline image
Mosaic ImmunoEngineering Expands Immuno-Oncology Platform Through New Technology Licensing Agreement with the University of California San Diego
From Mosaic ImmunoEngineering Inc.
Via AccessWire
Tickers CPMV
News headline image
Upcoming Presentation at the World Molecular Imaging Congress to Highlight Mosaic ImmunoEngineering’s Lead Immuno-Oncology and Modular Vaccine Platform COVID-19 Vaccine Candidates
From Mosaic ImmunoEngineering Inc.
Via AccessWire
Tickers CPMV
News headline image
Mosaic ImmunoEngineering Announces Keynote Presentation Highlighting its Modular Vaccine Platform Delivery Technology
From Mosaic ImmunoEngineering Inc.
Via AccessWire
Tickers CPMV
News headline image
Mosaic ImmunoEngineering Announces Publication of Data Supporting the Potential of Its SARS-CoV-2 Vaccine Candidates under its Modular Vaccine Platform
From Mosaic ImmunoEngineering Inc.
Via AccessWire
Tickers CPMV
News headline image
Mosaic ImmunoEngineering Expands Its Modular Vaccine Platform (MVP) Through New Technology Licensing Agreement with the University of California San Diego
From Mosaic ImmunoEngineering Inc.
Via AccessWire
Tickers CPMV
News headline image
Newly Published Preclinical Data Highlight Broad Immune Activation of Mosaic ImmunoEngineering’s Lead Intratumoral Immunotherapy Candidate, MIE-101
From Mosaic ImmunoEngineering Inc.
Via AccessWire
Tickers CPMV
News headline image
Mosaic ImmunoEngineering Submits Application for Nasdaq Uplisting
From Mosaic ImmunoEngineering Inc.
Via AccessWire
Tickers CPMV
News headline image
Mosaic ImmunoEngineering Inc. Elects Biotechnology Industry Veteran Robert A. Baffi, Ph.D. to Its Board of Directors
From Mosaic ImmunoEngineering Inc.
Via AccessWire
Topics Intellectual Property
Tickers CPMV
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.